- Home
- NTRB vs CSBR Comparison
NTRB vs CSBR Comparison
Compare NTRB & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- CSBR
- Stock Information
- Founded
- NTRB 2016
- CSBR 1985
- Country
- NTRB United States
- CSBR United States
- Employees
- NTRB N/A
- CSBR N/A
- Industry
- NTRB Industrial Specialties
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTRB Health Care
- CSBR Health Care
- Exchange
- NTRB Nasdaq
- CSBR Nasdaq
- Market Cap
- NTRB 87.2M
- CSBR 90.2M
- IPO Year
- NTRB N/A
- CSBR 1986
- Fundamental
- Price
- NTRB N/A
- CSBR N/A
- Analyst Decision
- NTRB Buy
- CSBR Strong Buy
- Analyst Count
- NTRB 1
- CSBR 1
- Target Price
- NTRB $13.00
- CSBR $12.00
- AVG Volume (30 Days)
- NTRB 29.0K
- CSBR 20.6K
- Earning Date
- NTRB 12-03-2025
- CSBR 09-15-2025
- Dividend Yield
- NTRB N/A
- CSBR N/A
- EPS Growth
- NTRB N/A
- CSBR N/A
- EPS
- NTRB N/A
- CSBR 0.21
- Revenue
- NTRB $2,578,059.00
- CSBR $56,878,000.00
- Revenue This Year
- NTRB $560.75
- CSBR $7.31
- Revenue Next Year
- NTRB $588.39
- CSBR $12.01
- P/E Ratio
- NTRB N/A
- CSBR $30.38
- Revenue Growth
- NTRB 42.92
- CSBR 10.11
- 52 Week Low
- NTRB $2.98
- CSBR $3.75
- 52 Week High
- NTRB $9.42
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- NTRB 53.26
- CSBR 49.11
- Support Level
- NTRB $7.02
- CSBR $6.29
- Resistance Level
- NTRB $8.63
- CSBR $6.89
- Average True Range (ATR)
- NTRB 0.46
- CSBR 0.22
- MACD
- NTRB -0.01
- CSBR 0.03
- Stochastic Oscillator
- NTRB 39.87
- CSBR 49.21
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.